High-Risk Coronary Plaque Regression After Intensive Lifestyle Intervention in Nonbstructive Coronary Disease: A Randomized Study
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Primary Prevention Trial Designs Using Coronary Imaging: A National Heart, Lung, and Blood Institute Workshop
Long-term effects of intensive glucose lowering on cardiovascular outcomes
Short-Term Progression of Multiterritorial Subclinical Atherosclerosis
Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial
Negative Risk Markers for Cardiovascular Events in the Elderly
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.